BioSpace News Archive

Sharps Compliance, Inc., a subsidiary of Sharps Compliance Corp., announced that it has received loan proceeds of $2.2 million under the Paycheck Protection Program under a promissory note from its commercial bank.

AIkido Pharma Inc. announced that on April 13, 2020, the Company executed a Master License Agreement with the University of Maryland, Baltimore.

Selexis SA, a JSR Life Sciences Company, announced that Great Place to Work® has recognized the Company as one of the “Best Workplaces in Switzerland 2020.” Selexis joins companies of all sizes from all industries whose employees think they have an especially trustworthy, appreciative and attractive workplace culture.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its wholly owned drug outsourcing facility, US Compounding Inc. (USC), has increased its product mix to provide additional drugs to assist in the ongoing fight against COVID-19.

Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that Bonus BioGroup (TASE: BONS.TA), a company in which Wize owns 8.9% of its equity securities, has initiated a preclinical study of its drug product candidate MesenCure,

Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it has successfully obtained re-registration of the T-SPOT.TB test in China.

Funding will support federally sponsored national Convalescent Plasma Expanded Access Program being led by Mayo Clinic

A consortium of leading healthcare companies today announced the launch of the COVID-19 Research Database , a secure repository of HIPAA-compliant, de-identified and limited patient-level data sets made available to public health and policy researchers to extract insights to help combat the COVID-19 pandemic. The database is a

– Overall response rate of 22% – – Disease control rate of 71% – – Median overall survival of 21 months – – Key topline data from ILLUMINATE-301 expected in Q1 2021 –

The partnership addresses key concerns for clinical trial sponsors as they transition to virtual trials in light of the COVID-19 pandemic [21-April-2020] LOS ANGELES and COLUMBIA, Md. , April 21, 2020 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite app